How to cite item

Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC

   
@article{CCO22320,
	author = {Tianhong Li and Weijie Ma and Eddie C. Tian},
	title = {Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC},
	journal = {Chinese Clinical Oncology},
	volume = {8},
	number = {Suppl 1},
	year = {2018},
	keywords = {},
	abstract = {Rearrangements of the anaplastic lymphoma kinase (ALK) gene were first identified in 2007 and occur in 3 to 5% of all patients with advanced non-small cell lung cancer (NSCLC) (1).},
	issn = {2304-3873},	url = {https://cco.amegroups.org/article/view/22320}
}